West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 720,000 | 730,800 | 706,500 | 723,600 | 670,700 |
| Cost of Goods | 435,400 | 430,200 | 418,300 | 408,500 | 398,800 |
| Gross Profit | 284,600 | 300,600 | 288,200 | 315,100 | 271,900 |
| Operating Expenses | 95,300 | 116,800 | 107,100 | 104,300 | 97,100 |
| Operating Income | 189,700 | 184,000 | 181,400 | 211,300 | 175,600 |
| Interest Expense | 2,200 | 2,600 | 1,800 | 1,900 | 1,900 |
| Other Income | 7,500 | 500 | 8,000 | 10,200 | 6,200 |
| Pre-tax Income | 195,000 | 181,900 | 187,600 | 219,600 | 179,900 |
| Income Tax | 21,200 | 34,200 | 12,000 | 32,300 | 28,700 |
| Net Income Continuous | 173,800 | 147,700 | 175,600 | 187,300 | 151,200 |
| Net Income | $173,800 | $147,700 | $175,600 | $187,300 | $151,200 |
| EPS Basic Total Ops | 2.34 | 1.95 | 2.37 | 2.53 | 2.04 |
| EPS Basic Continuous Ops | 2.34 | 1.95 | 2.37 | 2.53 | 2.05 |
| EPS Diluted Total Ops | 2.29 | 1.90 | 2.31 | 2.47 | 1.99 |
| EPS Diluted Continuous Ops | 2.29 | 1.89 | 2.31 | 2.47 | 1.99 |
| EBITDA(a) | $219,300 | $218,400 | $211,400 | $240,100 | $204,700 |